The Asia Pacific Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Pacific Examiner.

Press releases published on October 5, 2026

Oct. 5, 2026

The Internet of Things (IoT) Precision Agriculture Sensors Market Report Analyzes Segment Details & Business Approaches

Indeterminate EIN Presswire

Oct. 5, 2026

Internal Combustion Engine Market Expected to Grow Steadily at a 7.7% CAGR Until 2030

Indeterminate EIN Presswire

Oct. 5, 2026

The Integrated Backup and Recovery Services Market Is Projected to Grow at a 12.3% CAGR Through 2030

Indeterminate EIN Presswire

Oct. 5, 2026

Information Technology (IT) Services Outsourcing Market Report with Segment Analysis and Strategic Industry Insights

Indeterminate EIN Presswire

Oct. 5, 2026

Global Hybrid Electric Vehicles Market Expected to Exceed $191.9 Billion by 2030

Indeterminate EIN Presswire

Oct. 5, 2026

The In Vitro Fertilization (IVF) Clinic Insurance Market Is Projected to Grow to $6.68 Billion by 2030 with CAGR of 8.3%

Indeterminate EIN Presswire

Oct. 5, 2026

Aprea Therapeutics to Present at October Conferences

Indeterminate GlobeNewswire

Oct. 5, 2026

Medela Recognised by Australian Mums with Three MumPower Approved™ Seals

Indeterminate EIN Presswire

Oct. 5, 2026

Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101

Indeterminate GlobeNewswire

Oct. 5, 2026

BEYYON Rechargeable Hand Warmers with LED Displays: Two Market-Tested Cold-Weather Essentials, Each in a 2-Pack

Indeterminate GlobeNewswire

Oct. 5, 2026

PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Northern Discovery Metals Completes Fieldwork at the Vent Copper Project

Indeterminate GlobeNewswire

Oct. 5, 2026

Vortex Energy Commissions Hydrogen and Helium Study at Robinsons River Salt Project

Indeterminate GlobeNewswire

Oct. 5, 2026

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer

Indeterminate GlobeNewswire

Oct. 5, 2026

Cerevance Appoints Karl Kieburtz, M.D., M.P.H., as Chief Medical Officer

Indeterminate GlobeNewswire

Oct. 5, 2026

OnCusp Therapeutics Announces Positive Phase 1b Data Evaluating its CDH6-Directed Antibody-Drug Conjugate, CUSP06, in Platinum-Resistant Ovarian Cancer (PROC) Presented at Plenary Oral Session of the IGCS 2026 Annual Global Meeting

Indeterminate GlobeNewswire

Oct. 5, 2026

Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)

Indeterminate GlobeNewswire

Oct. 5, 2026

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

Indeterminate GlobeNewswire

Oct. 5, 2026

Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study

Indeterminate GlobeNewswire

Oct. 5, 2026

AGM Group Holdings Inc. Announces Closing of US$11.0 million Private Placement

Indeterminate GlobeNewswire